Vivo Capital, LLC Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$1.2B
Holdings
43
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 6,291,851 | $317.7T | 26290202.36% | |
| 2 | GONGeron Corp | 27,225,292 | $123.6T | 10229126.03% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $104.2T | 8627514.40% | |
| 4 | VRNAVerona Pharma PLC | 3,549,758 | $102.1T | 8451790.80% | |
| 5 | SVASinovac Biotech Ltd. | 11,800,000 | $76.3T | 6318244.34% | |
| 6 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $57.5T | 4759457.34% | |
| 7 | TILInstil Bio Inc | 624,339 | $42.0T | 3478361.34% | |
| 8 | DYNDyne Therapeutics Inc | 1,114,960 | $40.0T | 3314406.27% | |
| 9 | VRDNViridian Therapeutics Inc | 1,678,207 | $38.2T | 3159636.01% | |
| 10 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $35.2T | 2913255.52% | |
| 11 | SLNSilence Therapeutics PLC | 1,105,454 | $20.1T | 1663200.82% | |
| 12 | ZBIOZenas Biopharma Inc | 1,183,260 | $20.0T | 1656878.52% | |
| 13 | ERASErasca Inc | 6,756,756 | $18.4T | 1526549.93% | |
| 14 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $18.0T | 1487988.67% | |
| 15 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $17.1T | 1414753.60% | |
| 16 | TRMLTourmaline Bio Inc. | 591,882 | $15.2T | 1259352.57% | |
| 17 | RZLTRezolute Inc | 2,797,704 | $13.6T | 1122932.41% | |
| 18 | ORICOric Pharmaceuticals Inc | 1,277,818 | $13.1T | 1083934.43% | |
| 19 | SERASera Prognostics Inc | 1,650,440 | $12.9T | 1065379.83% | |
| 20 | COGTCogent Biosciences Inc | 1,122,471 | $12.1T | 1003249.66% | |
| 21 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $11.6T | 963815.38% | |
| 22 | CMPSCompass Pathway PLC | 1,608,000 | $10.1T | 838371.92% | |
| 23 | CELCCelcuity Inc | 610,500 | $9.1T | 753309.49% | |
| 24 | DCTHDelcath Systems, Inc. | 997,005 | $9.0T | 745066.79% | |
| 25 | CRVSCorvus Pharmaceuticals Holdings | 1,497,268 | $7.9T | 654249.79% | |
| 26 | RGLSRegulus Therapeutics Inc | 5,000,000 | $7.8T | 649650.51% | |
| 27 | ALXOALX Oncology Holdings Inc | 4,034,522 | $7.3T | 607678.12% | |
| 28 | CMPXCompass Therapeutics Inc | 3,556,023 | $6.5T | 541492.56% | |
| 29 | IOBTIO Biotech Inc | 6,173,439 | $6.5T | 536446.72% | |
| 30 | AVU0Adverum Biotechnologies, Inc. | 833,333 | $5.8T | 484134.29% | |
| 31 | TRVITrevi Therapeutics Inc | 1,612,903 | $5.4T | 445825.44% | |
| 32 | VSTMVerastem Inc | 1,538,461 | $4.6T | 380686.76% | |
| 33 | ENGNEngene Holdings Inc. | 678,705 | $4.5T | 370710.69% | |
| 34 | CRBPCorbus Pharmaceuticals Holdings | 166,794 | $3.4T | 284767.06% | |
| 35 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $2.3T | 188837.02% | |
| 36 | ALLKGUSDAllakos Inc | 2,956,110 | $1.9T | 159800.04% | |
| 37 | UNCYUnicycive Therapeutics | 4,470,152 | $1.8T | 150898.92% | |
| 38 | ALGSAligos Therapeutics Inc | 141,879 | $1.2T | 101682.47% | |
| 39 | CDXSCodexis, Inc | 388,144 | $1.2T | 98935.90% | |
| 40 | DBVTDBV Technologies SA | 1,354,437 | $948.1B | 78463.38% | |
| 41 | QTTBQ32 Bio Inc. | 20,559 | $917.3B | 75917.50% | |
| 42 | TENXTenax Therapeutics Inc | 208,333 | $720.8B | 59654.63% | |
| 43 | DTILPrecision Biosciences Inc | 4,675 | $41.9B | 3466.57% |